Company Name Iconic Therapeutics
Mailing Address 395 Oyster Point Boulevard South San Francisco, CA 94080 USA
Company Description Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Our deep understanding of the role of Tissue Factor (TF) in angiogenesis, inflammation, and metastasis has led us to develop a new approach to retinal disease and cancer. Our lead product candidate, ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of acute vision loss in AMD.
Proceeds Purposes Proceeds from the financing will be used to advance development of lead molecule ICON-1 in retinal diseases as well as begin clinical trials in ocular melanoma, Iconic’s first oncology indication. With new capital, Iconic expects to continue to add key talent to advance and expand the broad opportunities that may be addressed with a Tissue Factor-based approach.